Dorsey Wright & Associates’s Synovus SNV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-5,240
Closed -$245K 153
2025
Q1
$245K Buy
+5,240
New +$270K 0.06% 120
2021
Q3
Sell
-67,474
Closed -$2.96M 330
2021
Q2
$2.96M Sell
67,474
-409
-0.6% -$19.2K 0.63% 74
2021
Q1
$3.11K Buy
+67,883
New +$2.84M 0.04% 218

Other funds holding SNV

Dorsey Wright & Associates's SNV Position: Q2 2025 in Review

Dorsey Wright & Associates sold out of Synovus (SNV) in Q2 2025, closing a stake of 5,240 shares — an estimated $245K sold.

Dorsey Wright & Associates first reported a position in SNV in Q1 2021 and held it in 3 quarters. The position peaked at $2.96M in Q2 2021. 475 funds tracked by Wall St. Rank hold SNV as of Q2 2025.

  • Dorsey Wright & Associates reported no remaining Synovus position as of Q2 2025 after selling out during the quarter.
  • Dorsey Wright & Associates sold 5,240 Synovus shares in Q2 2025, an estimated $245K.
  • Dorsey Wright & Associates first reported a position in Synovus in Q1 2021 and held it in 3 quarters.
  • Dorsey Wright & Associates's Synovus position peaked at $2.96M in Q2 2021.
  • 475 funds tracked by Wall St. Rank held Synovus as of Q2 2025.

Based on Dorsey Wright & Associates's 13F filing for Q2 2025, filed 11 Aug 2025.